Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.

Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.

Tissue inhibitor of metalloproteinase-3 (TIMP-3) is a dual inhibitor of the matrix metalloproteinases (MMPs) and some adamalysins, two families of extracellular and cell surface metalloproteinases that function in extracellular matrix turnover and the shedding of cell surface proteins. The mechanism...

Bibliografiset tiedot
Päätekijät:	Wei, S, Kashiwagi, M, Kota, S, Xie, Z, Nagase, H, Brew, K
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2005

Samankaltaisia teoksia

Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
Tekijä: Nagase, H, et al.
Julkaistu: (2003)

Tissue inhibitors of metalloproteinases: evolution, structure and function.
Tekijä: Brew, K, et al.
Julkaistu: (2000)

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
Tekijä: Visse, R, et al.
Julkaistu: (2003)

Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics.
Tekijä: Nagase, H, et al.
Julkaistu: (2002)

Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP.
Tekijä: Black, R, et al.
Julkaistu: (1996)

Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.
Tekijä: Wei, S, et al.
Julkaistu: (2003)

The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.
Tekijä: Brew, K, et al.
Julkaistu: (2010)

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
Tekijä: Chandler, S, et al.
Julkaistu: (1997)

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) - Physiological roles and structural basis of MMP inhibition by TIMP-1
Tekijä: Nagase, H, et al.
Julkaistu: (2000)

Matrix metalloproteinases and their inhibitors in human vitreous.
Tekijä: De La Paz, MA, et al.
Julkaistu: (1998)

Zymography of metalloproteinases.
Tekijä: Troeberg, L, et al.
Julkaistu: (2004)

Competitive disruption of the tumor-promoting function of membrane type 1 matrix metalloproteinase/matrix metalloproteinase-14 in vivo.
Tekijä: Nonaka, T, et al.
Julkaistu: (2005)

Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma.
Tekijä: Ogata, Y, et al.
Julkaistu: (2001)

Structural features of the reprolysin atrolysin C and tissue inhibitors of metalloproteinases (TIMPs) interaction.
Tekijä: Pinto, A, et al.
Julkaistu: (2006)

Matrix metalloproteinases in cancer.
Tekijä: Itoh, Y, et al.
Julkaistu: (2002)

Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase.
Tekijä: Itoh, Y, et al.
Julkaistu: (1995)

Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors.
Tekijä: Ahonen, M, et al.
Julkaistu: (2003)

Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors
Tekijä: Ahonen, M, et al.
Julkaistu: (2002)

Progress in matrix metalloproteinase research.
Tekijä: Murphy, G, et al.
Julkaistu: (2008)

Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents.
Tekijä: Oltenfreiter, R, et al.
Julkaistu: (2006)

Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
Tekijä: Itoh, Y, et al.
Julkaistu: (1995)

A personal journey with matrix metalloproteinases
Tekijä: Nagase, H
Julkaistu: (2016)

Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
Tekijä: Ogata, Y, et al.
Julkaistu: (1995)

Enzymic Milk Clotting Activities of Metalloproteinase Kistomin
Tekijä: Jaya Vejayan, Palliah, et al.
Julkaistu: (2020)

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy.
Tekijä: Brennan, F, et al.
Julkaistu: (1997)

Structure and function of matrix metalloproteinases and TIMPs.
Tekijä: Nagase, H, et al.
Julkaistu: (2006)

Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
Tekijä: Itoh, Y, et al.
Julkaistu: (1998)

Localizing matrix metalloproteinase activities in the pericellular environment.
Tekijä: Murphy, G, et al.
Julkaistu: (2011)

Metalloproteinases in health and disease: challenges and the future prospects.
Tekijä: Nagase, H, et al.
Julkaistu: (2011)

Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.
Tekijä: Zhao, H, et al.
Julkaistu: (2004)

Role of matrix metalloproteinase 9 in pituitary tumor behavior.
Tekijä: Turner, H, et al.
Julkaistu: (2000)

Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis.
Tekijä: Murphy, F, et al.
Julkaistu: (2002)

Monitoring metalloproteinase activity using synthetic fluorogenic substrates.
Tekijä: Troeberg, L, et al.
Julkaistu: (2004)

Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?
Tekijä: Murphy, G, et al.
Julkaistu: (2008)

Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.
Tekijä: Tousoulis, D, et al.
Julkaistu: (2010)

Importance of matrix metalloproteinases in human trophoblast invasion.
Tekijä: Bischof, P, et al.
Julkaistu: (1995)

The expression of tissue inhibitor of metalloproteinase 2 (TIMP-2) is required for normal development of zebrafish embryos.
Tekijä: Zhang, J, et al.
Julkaistu: (2003)

Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells.
Tekijä: Bafetti, L, et al.
Julkaistu: (1998)

Selective hydrolysis of triple-helical peptides by matrix metalloproteinases
Tekijä: Lauer-Fields, J, et al.
Julkaistu: (2000)

Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling.
Tekijä: Kopitz, C, et al.
Julkaistu: (2007)